Phase 2 neurotoxicity Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Not Yet Recruiting
Phase 2
LANTERN - LAser Nerve ThERapy for chemotherapy Neurotoxicity
neurotoxicity
Concord Cancer Centre45 enrolled1 locationACTRN12619001672145
Recruiting
Phase 2
OXTOX: Can Oxaliplatin neurotoxicity be reduced with ibudilast in people with metastatic colorectal cancer – a phase II randomised study
Neurotoxicity caused by oxaliplatin in patients with metastatic colorectal cancer
Australasian Gastro-Intestinal Trials Group100 enrolled10 locationsACTRN12619000566134
Completed
Phase 2
Does Riluzole reduce the incidence of chemotherapy-induced nerve injury in patients with colorectal cancer?
Oxaliplatin-induced neurotoxicity
Prince of Wales Hospital/South Eastern Sydney Local Health Network100 enrolled1 locationACTRN12611000514909